US holds CBD hearing as fans, sellers await legal clarity
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Digital Subscription
One year of digital access for only $205*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*First annual payment billed as $205.00 + GST for one year. This annual subscription will automatically renew at $233.00 + GST every 52 weeks (10% off the regular annual price of $259.35). Offer available to new and qualified returning subscribers only. Cancel any time.
To continue reading, please subscribe:
Add Free Press access to your Brandon Sun subscription for only an additional
$1 for the first 4 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Your next Brandon Sun subscription payment will increase by $1.00 and you will be charged $17.95 plus GST for four weeks. After four weeks, your payment will increase to $24.95 plus GST every four weeks.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 31/05/2019 (2671 days ago), so information in it may no longer be current.
SILVER SPRING, Md. – CBD products have surged in popularity despite confusion around their legal status . Now U.S. regulators are exploring ways the hemp ingredient might officially be allowed in food, drinks and dietary supplements.
The U.S. Food and Drug Administration held a hearing Friday to collect information about cannabis compounds such as CBD, which is already available in candy, syrups, oils, drinks, skin patches and dog food.
No decisions are expected immediately, but the hearing is seen as an important step toward clarifying regulations around the ingredient.
“There is mass confusion in the marketplace,” said Peter Matz of the Food Marketing Institute, one of dozens of speakers who addressed the FDA panel.
Other speakers including academic researchers, businesses and consumer advocates urged the FDA to move quickly, noting that the industry is growing rapidly with little oversight. That is raising concerns about the accuracy of product labels and people not realizing how much they may be consuming through various products.
Before the hearing began, acting FDA Commissioner Ned Sharpless noted critical questions remain about the safety of CBD, such as how much is safe to use daily and the compound’s effects on pregnant women and children.
CBD often comes from a cannabis plant known as hemp, which is defined by the U.S. government as having less than 0.3% THC, the compound that causes marijuana’s mind-altering effect. CBD doesn’t cause that high, but fans of the products claim benefits including relief for pain and anxiety.
For now, the FDA has said CBD is not allowed in food, drinks and supplements. But given the agency’s limited resources, many do not expect the agency to enforce the position unless products make explicit health claims that could endanger people.
Adding to the confusion, some states like Colorado allow it in food and drinks. In New York City, where officials have warned it’s not allowed in food and drinks, restaurants and stores have continued selling it.
___
Follow Candice Choi on Twitter: @candicechoi
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
